StockData
Theriva Biologics, Inc. logo

Theriva Biologics, Inc. (TOVX) stock

TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.14+0.00 (+2.86%)

Close on Nov 18, 2026Market cap $6.61MP/E –Yield –

Theriva Biologics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2010 it was -65.5%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2010Dec 31, 2010-65.5%–

More Theriva Biologics figures

See a number that looks wrong?